HOLOGIC INC (HOLX)

US4364401012 - Common Stock

75.91  -0.37 (-0.49%)

After market: 78 +2.09 (+2.75%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to HOLX. HOLX was compared to 192 industry peers in the Health Care Equipment & Supplies industry. HOLX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HOLX is not valued too expensively and it also shows a decent growth rate.



8

1. Profitability

1.1 Basic Checks

In the past year HOLX was profitable.
HOLX had a positive operating cash flow in the past year.
HOLX had positive earnings in 4 of the past 5 years.
HOLX had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

HOLX's Return On Assets of 6.08% is amongst the best of the industry. HOLX outperforms 85.94% of its industry peers.
Looking at the Return On Equity, with a value of 11.07%, HOLX belongs to the top of the industry, outperforming 86.98% of the companies in the same industry.
With an excellent Return On Invested Capital value of 8.92%, HOLX belongs to the best of the industry, outperforming 88.54% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HOLX is significantly above the industry average of 8.53%.
The 3 year average ROIC (16.15%) for HOLX is well above the current ROIC(8.92%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 6.08%
ROE 11.07%
ROIC 8.92%
ROA(3y)13.44%
ROA(5y)10.53%
ROE(3y)26.72%
ROE(5y)22.35%
ROIC(3y)16.15%
ROIC(5y)14.15%

1.3 Margins

The Profit Margin of HOLX (12.98%) is better than 89.58% of its industry peers.
HOLX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 22.78%, HOLX belongs to the top of the industry, outperforming 95.31% of the companies in the same industry.
In the last couple of years the Operating Margin of HOLX has grown nicely.
HOLX has a Gross Margin (55.44%) which is in line with its industry peers.
In the last couple of years the Gross Margin of HOLX has remained more or less at the same level.
Industry RankSector Rank
OM 22.78%
PM (TTM) 12.98%
GM 55.44%
OM growth 3Y-8.49%
OM growth 5Y8.14%
PM growth 3Y-27.37%
PM growth 5YN/A
GM growth 3Y-2.18%
GM growth 5Y1.16%

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HOLX is creating some value.
The number of shares outstanding for HOLX has been reduced compared to 1 year ago.
The number of shares outstanding for HOLX has been reduced compared to 5 years ago.
Compared to 1 year ago, HOLX has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 4.38 indicates that HOLX is not in any danger for bankruptcy at the moment.
HOLX's Altman-Z score of 4.38 is fine compared to the rest of the industry. HOLX outperforms 75.00% of its industry peers.
HOLX has a debt to FCF ratio of 3.00. This is a good value and a sign of high solvency as HOLX would need 3.00 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 3.00, HOLX belongs to the best of the industry, outperforming 86.98% of the companies in the same industry.
HOLX has a Debt/Equity ratio of 0.55. This is a neutral value indicating HOLX is somewhat dependend on debt financing.
HOLX has a worse Debt to Equity ratio (0.55) than 65.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 3
Altman-Z 4.38
ROIC/WACC0.93
WACC9.57%

2.3 Liquidity

HOLX has a Current Ratio of 3.89. This indicates that HOLX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of HOLX (3.89) is comparable to the rest of the industry.
HOLX has a Quick Ratio of 3.18. This indicates that HOLX is financially healthy and has no problem in meeting its short term obligations.
HOLX has a Quick ratio of 3.18. This is in the better half of the industry: HOLX outperforms 60.42% of its industry peers.
Industry RankSector Rank
Current Ratio 3.89
Quick Ratio 3.18

4

3. Growth

3.1 Past

The earnings per share for HOLX have decreased strongly by -21.38% in the last year.
HOLX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.01% yearly.
HOLX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.12%.
Measured over the past years, HOLX shows a small growth in Revenue. The Revenue has been growing by 4.61% on average per year.
EPS 1Y (TTM)-21.38%
EPS 3Y-0.42%
EPS 5Y12.01%
EPS growth Q2Q-8.41%
Revenue 1Y (TTM)-11.12%
Revenue growth 3Y2.19%
Revenue growth 5Y4.61%
Revenue growth Q2Q-5.69%

3.2 Future

The Earnings Per Share is expected to grow by 9.69% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.18% on average over the next years.
EPS Next Y4.01%
EPS Next 2Y6.49%
EPS Next 3Y7.58%
EPS Next 5Y9.69%
Revenue Next Year0.15%
Revenue Next 2Y2.72%
Revenue Next 3Y3.79%
Revenue Next 5Y5.18%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.67, which indicates a rather expensive current valuation of HOLX.
HOLX's Price/Earnings ratio is rather cheap when compared to the industry. HOLX is cheaper than 87.50% of the companies in the same industry.
HOLX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.06.
Based on the Price/Forward Earnings ratio of 16.95, the valuation of HOLX can be described as correct.
89.06% of the companies in the same industry are more expensive than HOLX, based on the Price/Forward Earnings ratio.
HOLX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.72.
Industry RankSector Rank
PE 19.67
Fwd PE 16.95

4.2 Price Multiples

HOLX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HOLX is cheaper than 86.98% of the companies in the same industry.
91.15% of the companies in the same industry are more expensive than HOLX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.75
EV/EBITDA 15.08

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HOLX does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of HOLX may justify a higher PE ratio.
PEG (NY)4.91
PEG (5Y)1.64
EPS Next 2Y6.49%
EPS Next 3Y7.58%

0

5. Dividend

5.1 Amount

HOLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HOLOGIC INC

NASDAQ:HOLX (5/2/2024, 7:00:01 PM)

After market: 78 +2.09 (+2.75%)

75.91

-0.37 (-0.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap17.82B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 19.67
Fwd PE 16.95
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.91
PEG (5Y)1.64
Profitability
Industry RankSector Rank
ROA 6.08%
ROE 11.07%
ROCE
ROIC
ROICexc
ROICexgc
OM 22.78%
PM (TTM) 12.98%
GM 55.44%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.89
Quick Ratio 3.18
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-21.38%
EPS 3Y-0.42%
EPS 5Y
EPS growth Q2Q
EPS Next Y4.01%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.12%
Revenue growth 3Y2.19%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y